---
title: Adaptive multi-interventional trial platform to improve patient care for fibrotic
  interstitial lung diseases
date: '2024-03-06'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38448221/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240307170638&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: By using an innovative and efficient adaptive multi-interventional
  trial platform design, we aim to accelerate and improve care for patients with fILD.
  Through worldwide collaboration, novel analytical methodology and pragmatic trial
  delivery, REMAP-ILD aims to overcome major limitations associated with conventional
  randomised controlled trial approaches to rapidly improve the care of people living
  with ...'
disable_comments: true
---
CONCLUSION: By using an innovative and efficient adaptive multi-interventional trial platform design, we aim to accelerate and improve care for patients with fILD. Through worldwide collaboration, novel analytical methodology and pragmatic trial delivery, REMAP-ILD aims to overcome major limitations associated with conventional randomised controlled trial approaches to rapidly improve the care of people living with ...